Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy

Clinica Chimica Acta

Volumn 287, Issue 1-2, 1999, Pages 99-109

  Fujita, Toru ^a   Amuro, Yoshiki ^a   Hada, Toshikazu ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Aminobutyric acid; Enantiomer; Hepatic encephalopathy and intestinal bacteria; Pipecolic acid

Indexed keywords

KANAMYCIN; PIPECOLIC ACID;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENANTIOMER; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTESTINE FLORA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; CHRONIC DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PIPECOLIC ACIDS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 0032847770     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00123-0     Document Type: Article

References (23)

1. Hutzler J., Dancis J. The determination of pipecolic acid: method and results of hospital survey. Clin Chim Acta. 128:1983;75-82.
2. Higashino K., Tsukada K., Lieberman I. Saccharopine, a product of lysine breakdown by mammalian liver. Biochem Biophys Res Commun. 20:1965;285-290.
3. Higashino K., Fujioka M., Aoki T., Yamamura Y. Metabolism of lysine in rat liver. Biochem Biophys Res Commun. 29:1967;95-100.
4. Higashino K., Fujioka M., Yamamura Y. The conversion of L-lysine to saccharopine and α-aminoadipate in mouse. Arch Biochem Biophys. 142:1971;606-614.
5. Cox R.P., Dancis J. Errors of lysine metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Walle D. 7th ed The metabolic and molecular bases of inherited disease. Vol. 1:1995;1233-1238 McGraw-Hill, New York.
6. Kawasaki H., Hori T., Nakajima M., Takeshita K. Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology. 8:1988;286-289.
7. Matsuda Y., Higashino K., Adachi K., Amuro Y., Hada T. Production of pipecolic acid from intestinal bacteria: Plasma levels of pipecolic acid in patients with liver cirrhosis decreased after oral kanamycin administration. Int Hepatology Commun. 4:1995;26-34.
8. Armstrong D.W., Gasper M., Lee S.H., Zukowski J., Ercal N. D-amino acid levels in human physiological fluids. Chirality. 5:1993;375-378.
9. Armstrong DW, Zukowski J, Ercal, Gasper M. Stereochemistry of pipecolic acid found in the urine and plasma of subjects with peroxisomal deficiencies. J Pharm and Biomedical Anals 1993;11:881-6.
10. Charles A.K. Pipecolic acid receptors in rat cerebral cortex. Neurochem Res. 11:1986;521-525.
11. Takahama K., Miyata T., Hashimoto T., Okano Y., Kase Y. Pipecolic acid: A new type of α-amino acid possessing bicuculline-sensitive action in the mammalian brain. Brain Res. 239:1982;294-298.
12. Jones E.A. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story. Hepatology. 14:1991;1286-1290.
13. Steindl P., Püspök A., Druml W., Ferenci P. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: Comparison with uremic encephalopathy. Hepatology. 14:1991;963-968.
14. Gammal S.H., Basile A.S., Geller D., Skolnick P., Jones E.A. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology. 11:1990;371-378.
15. Mullen K.D., Szauter K.M., Kaminsky-Russ K. 'Endogenous' benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet. 336:1990;81-83.
16. Nishio H., Segawa T. Determination of pipecolic acid in human blood plasma by high-performance liquid chromatography. Clin Chim Acta. 143:1984;57-63.
17. Giacobini E., Nomura Y., Schmidt-Glenewinkel T. Pipecolic acid: origin, biosynthesis and metabolism in the brain. Cell Mol Biol. 26:1980;135-146.
18. Floch M.H., Katz J., Conn H.O. Qualitive and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis. Gastroenterology. 59:1970;70-75.
19. Schmidt-Glenewinkel T., Nomura Y., Giacobini E. The conversion of lysine into piperidine, cadaverine, and pipecolic acid in the brain and other organs of the mouse. Neurochem Res. 2:1977;619-637.
20. Chang Y.F. Lysine metabolism in the rat brain: Blood-brain barrier transport, formation of pipecolic acid and human hyperpipecolatemia. J Neurochem. 30:1978;355-360.
21. Gutierrez M.D.C., Giacobini E. Identification and characterization of pipecolic acid binding sites in mouse brain. Neurochem Res. 10:1985;691-702.
22. Chang Y.F., Hargest V., Chen J.S. Modulation of benzodiazepine by lysine and pipecolic acid on pentylenetetrazol-induced seizures. Life Sci. 43:1988;1177-1188.
23. Beitz A.J., Larson A.A. Inhibition of intrathecally administered picrotoxin- and bicuculline-induced convulsions in mice by pipecolic acid or GABA. European J Pharmacol. 114:1985;181-187.